Swedish Orphan Biovitrum AB (SOBI) NPV

Sell:439.60 SEKBuy:440.00 SEKPrice increased4.60 SEK (1.05%)

Market closed |
Prices delayed by at least 15 minutes
Sell:439.60 SEK
Buy:440.00 SEK
Change:Price increased4.60 SEK (1.05%)
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:439.60 SEK
Buy:440.00 SEK
Change:Price increased4.60 SEK (1.05%)
Market closed |
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open439.20 SEK
Previous close437.60 SEK
Market capSEK 156.40bn
P/E ratio30.05
Volume2,816,467
Dividend yield0.00%
EMS-

Company information

Swedish Orphan Biovitrum AB (publ) is a Sweden-based pharmaceutical company. The Company develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive ...

  • LocationSweden
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencySEK
  • Shares in issue357.41m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Balance sheet 2025

Total assetsSEK 67.43bn
Total liabilitiesSEK 29.72bn
Net debtSEK 5.66bn

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.